Home / Healthcare / Pharmaceutical / U.S. Opioid Use Disorder (OUD) Market

U.S. Opioid Use Disorder (OUD) Market Size, Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies), and Country Forecast, 2024-2032

Report Format: PDF | Published Date: Sep, 2024 | Report ID: FBI108778 | Status : Published
















































ATTRIBUTE



DETAILS



Study Period



2019-2032



Base Year



2023



Estimated Year



2024



Forecast Period



2024-2032



Historical Period



2019-2022



Growth Rate



CAGR of 9.9% from 2024 to 2032



Unit



Value (USD Billion)



Segmentation



By Drug Class



  • Buprenorphine

  • Methadone

  • Naltrexone



By Route of Administration



  • Oral

  • Parenteral



By Distribution Channel



  • Hospital Pharmacies

  • Retail Pharmacies & Stores

  • Online Pharmacies


  • USA
  • 2023
  • 2019-2022
  • 80
  • PRICE
  • $ 2850
    $ 3850
    $ 4850
    Buy Now

Healthcare Clients